feed
S&P 500
NASDAQ
DOW
VIX
US10Y
EUR/USD
GOLD
WTI
BTC
AArphra
Arphra/Issuer/TORNTPHARM.BO

TORNTPHARM.BO

Torrent Pharmaceuticals Limited
HealthcareDrug Manufacturers - Specialty & GenericININRCountry macro →
$4,285.05
Jun 02, 2026
AI Brief
Revenue · FY
$139.8B
Net income
$21.63B
FY 2026
EPS · diluted
$63.92
EBITDA
$34.62B

Explain this page

Arphra AI

Company profile

DB · companies + sec_company_profile + company_profiles

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including cardiovascular, central nervous system, gastro-intestinal, and women healthcare; and diabetology, pain management, gynecology, oncology, and anti-infective, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

Headquarters
Torrent House, Ahmedabad, 380009
IN
Phone
91 79 2659 9000
AI description
Arphra AI
Loading cached description…

Identifiers

  • SymbolTORNTPHARM.BO
  • Legal nameTorrent Pharmaceuticals Limited
  • CEOSanjay Gupta
  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CountryIN
  • CurrencyINR
  • ExchangeBSE
  • IPO dateJan 03, 2000
  • CIK
  • ISININE685A01028
  • CUSIP
  • LEI
  • Employees15,718

Trading

DB · key_metrics_ttm
  • Market cap$1.48T
  • P/E (TTM)
  • P/B
  • EV / EBITDA
  • Dividend yield